Crook 1996.
Methods | multicentre, double blind, randomized, placebo controlled, parallel groups | |
Participants | SDAT mild to moderate; 74 patients received nicergoline, 75 placebo; age > 50 yr. | |
Interventions | Nicergoline or Placebo 30mg. twice a day (os) for 6 months | |
Outcomes | ADAScog, CGIC for efficacy; adverse events for safety | |
Notes | ITT (LOCF) analysis is available |